This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor 2 hours ago
MarketsTrading IdeasNewsAnalyst RatingsUpgrades
Wall Street analysts upgraded EW, MSGK, OUST, NVTS; EW, OUST and NVTS also received price-target updates.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Truist Securities analyst Richard Newitter upgraded Edwards Lifesciences Corp (NYSE:EW) from Hold to Buy and raised the price target from $95 to $113. Edwards Lifesciences closed at $95.19 on Tuesday. See how other analysts view this stock.
- Wolfe Research analyst Peter Supino upgraded MSG Knickerbockers Corp. (NYSE:MSGK) from Peer Perform to Outperform. MSG Knickerbockers shares closed at $314.84 on Tuesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Andres Sheppard upgraded Ouster, Inc. (NASDAQ:OUST) from Neutral to Overweight and announced a $45 price target. Ouster closed at $28.98 on Tuesday. See how other analysts view this stock.
- Rosenblatt analyst Kevin Cassidy upgraded Navitas Semiconductor Corporation (NASDAQ:NVTS) from Neutral to Buy and maintained the price target of $13. Navitas Semiconductor shares closed at $8.56 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Thomas Palmer upgraded Archer-Daniels-Midland Company (NYSE:ADM) from Underweight to Neutral and maintained the price target of $75. ADM closed at $70.60 on Monday. See how other analysts view this stock.
Considering buying EW stock? Here’s what analysts think:

Photo via Shutterstock
